Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Human single-cell atlas of proliferative diabetic retinopathy reveals a SOX15-overexpressing stromal population driving retinal fibrosis through the endothelin-1 -EDNRB axis

Proliferative diabetic retinopathy (PDR) is a leading cause of irreversible blindness worldwide, characterized by pathological neovascularization and progressive retinal fibrosis. Although anti-VEGF therapy effectively suppresses neovascularization, it does not address fibrovascular membranes (FVMs) formation and may paradoxically accelerate membrane contraction, increasing the risk of tractional retinal detachment. The lack of effective anti-fibrotic strategies highlights the importance to elucidate the key cellular mechanisms underlying retinal fibrosis in PDR. We performed single-cell RNA sequencing (scRNA-seq) on primary retinal tissues from PDR organ donors and non-diabetic controls, generating a single-cell transcriptomic atlas of the human PDR retina. Critical findings were validated by immunofluorescence, in vivo and in vitro functional assays. Stromal-specific Sox15 conditional knockout mice in a two-stage laser-induced fibrosis model and siRNA-mediated knockdown in fibroblasts, and intravitreal administration of the EDNRB antagonist were performed. scRNA-seq of primary human PDR retinas generated the first comprehensive single-cell transcriptomic atlas of human PDR, revealing profound alterations in cellular composition including microglial expansion and Müller glia reprogramming as central neuroinflammatory features of PDR, and selective loss of metallothionein enriched rods subpopulation and S-cones. Notably, We identified a stromal cell population that was enriched in PDR retinas, localized in FVMs, and characterized by high SOX15 expression. Cell-cell communication analysis revealed that EDN1-EDNRB signaling between these stromal cells and Müller glia represented the most prominent intercellular interaction in PDR. Mechanistically, SOX15 regulates EDN1 transcription through binding to its promoter, driving EDN1 expression that activates EDNRB-expressing retinal macroglia to promote reactive gliosis and retinal fibrosis. Stromal-specific Sox15 conditional knockout significantly attenuated fibrotic lesion formation in vivo, and PDR-derived fibrocytes with elevated SOX15 exhibited enhanced fibroblast differentiation and EDN1 secretion, providing translational validation in human disease. Intravitreal EDNRB blockade with BQ-788 significantly reduced fibrotic area in a murine fibrosis model. This study identifies key pathological features of the human PDR retina, including pervasive neuroinflammation and selective loss of photoreceptor subpopulations, and delineates the SOX15–EDN1-EDNRB axis as a novel mechanism driving retinal fibrosis. Targeting this axis may represent a promising anti-fibrotic strategy for advanced PDR.

F. Tang, Wenjing He, Zhijie Niu et al. · 0 citations
Open access Aug 2026

A novel hypoxia-related signature for predicting prognosis, immune characteristics, and therapeutic response in hepatocellular carcinoma

This study aimed to develop and validate a hypoxia-related gene signature for prognostic assessment in hepatocellular carcinoma (HCC) and to explore its associated biological characteristics and immune features. In addition, a self-established human tissue cohort was used to verify the expression stability of the identified signature genes. The TCGA-LIHC cohort was used as the training set to identify differentially expressed hypoxia-related genes associated with overall survival. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression analyses were subsequently applied to construct a prognostic model. The predictive performance of the model was externally validated using the GSE14520 and GSE116174 cohorts. Functional enrichment and immune microenvironment analyses were performed to characterize the biological differences between risk groups. Furthermore, quantitative real-time PCR (qRT-PCR) was conducted in a human tissue cohort, including normal liver tissues, adjacent non-tumorous tissues, and HCC tissues, to validate the expression patterns of the four signature genes (TMEM45A, PPARGC1A, EFNA3, and STC2). A four-gene hypoxia-related prognostic signature was established and successfully stratified patients into high- and low-risk groups. Patients in the high-risk group exhibited significantly poorer overall survival in both the training and validation cohorts. Functional enrichment analyses revealed that high-risk tumors were associated with activation of pathways related to cell-cycle progression, MYC targets, epithelial–mesenchymal transition, and metabolic reprogramming. Immune analyses demonstrated increased M0 macrophage infiltration and elevated expression of multiple immune checkpoint genes in the high-risk group. qRT-PCR validation further confirmed the differential expression patterns of the four signature genes in human HCC tissues. This four-gene hypoxia-related signature demonstrated robust prognostic performance across multiple independent cohorts and was associated with distinct metabolic and immune characteristics in HCC. qRT-PCR validation further supported the expression stability of the identified genes in human tissues. These findings provide a useful framework for prognostic stratification and future investigation of hypoxia-related biological mechanisms and therapeutic strategies in HCC.

Chengting Wu, Yuanqin Du, Juhong Jia et al. · 0 citations